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Abstract
It is often quite demanding for clinicians to diagnose
the different forms of central ocular motor disorders and
the nystagmus associated with them. There are three re-
asons for this: first, the anatomy and the physiology of the
ocular motor, vestibular, and cerebellar systems are com-
plex; second, the detailed neurological and neuro-ophthal-
mological as well as neuro-otological examinations requ-
ire a systematic approach, precise skills, and experience;
third, it is often difficult to interpret the findings, and cli-
nical experience is required to do so. Therefore, a standar-
dized approach with careful taking of the patient’s medi-
cal history and a neurological, neuro-ophthalmological and
neuro-otological examination are crucial for the diagno-
sis. For common central ocular motor disorders like do-
wnbeat nystagmus the new treatment option with amino-
pyridines improves gait and gaze stability in these patients.
Clinical examination
Clinical examination of patients with suspected ocu-
lar motor disorders should begin with the examination
of the eyes in nine different positions (i.e., looking stra-
ight ahead, to the right, left, up, down as well as diago-
nally right up, right down, left up, and left down) to de-
termine ocular alignment, fixation deficits, spontaneous
or fixation nystagmus, range of movement, and disorders
of gaze-holding abilities. The examination can be perfor-
med with an object for fixation or a small rod-shaped
flashlight. In primary position one should look for pe-
riodic eye movements, such as nystagmus (e.g., horizon-
tal-rotatory, suppressed by fixation as in peripheral ve-
stibular dysfunction), vertically upward (upbeat nystag-
mus) or downward (downbeat nystagmus), or horizon-
tal or torsional movements with only slight suppression
of intensity during fixation as in a central vestibular dys-
function. A congenital nystagmus beats, as a rule, hori-
zontally at various frequencies and amplitudes and in-
creases during fixation. Ocular flutter (intermittent ra-
pid bursts of horizontal oscillations without an intersac-
cadic interval) or opsoclonus (combined horizontal,
vertical, and torsional oscillations) occur in various di-
sorders such as encephalitis, tumors of the brainstem or
cerebellum, intoxication, or in paraneoplastic syndromes.
The examination of the eyes with Frenzel’s glasses is
a sensitive method for detecting spontaneous nystagmus.
This can also be achieved by examining one eye with an
ophthalmoscope (while the other eye is covered) and si-
multaneously checking for movements of the optic papil-
la or retinal vessels even with low, slow-phase velocities/
/frequencies.
After checking for possible eye movements in primary
position and the misalignment of the axes of the eyes, the
examiner should then establish the range of eye movements
monocularly and binocularly in the eight end-positions;
deficits found here can indicate, e.g., extraocular muscle or
nerve palsy. Gaze-holding deficits can also be determi-
ned by examining eccentric gaze position. Use of a small
rod-shaped flashlight has the advantage that the corneal
reflex images can be observed and thus ocular misalign-
ments can be easily detected. The flashlight also allows one
to determine whether the patient can fixate with one or
both eyes in the end-positions. This is important for detec-
ting a defect of gaze holding. Gaze-evoked nystagmus can
only be clearly identified when the patient fixates with both
eyes. It is most often a side effect of medication (e.g., anti-
convulsants, benzodiazepines) or toxins (e.g., alcohol).
Horizontal gaze-evoked nystagmus can indicate a structural
lesion in the area of the brainstem or cerebellum, i.e., the
neural eye velocity to position integrator). Vertical gaze-
evoked nystagmus is observed in midbrain lesions invol-
ving the interstitial nucleus of Cajal. A dissociated hori-
zontal gaze-evoked nystagmus (greater in the abducting
than the adducting eye) in combination with an adduction
deficit points to internuclear ophthalmoplegia (INO) due
to a defect of the medial longitudinal fascicle (MLF), ipsila-
teral to the adduction deficit. Downbeat nystagmus usual-
ly increases in eccentric gaze position and when looking
down. To examine for a so-called rebound nystagmus the
patient should gaze at least 15 seconds to one side and then
return the eyes to the primary position; this can cause
a transient nystagmus to appear with slow phases in the
direction of the previous eye position. Rebound nystagmus
generally indicates cerebellar dysfunction or damage to the
cerebellar pathways.
To examine smooth pursuit the patient is asked to vi-
sually track an object moving slowly in horizontal and
vertical directions (10 to 20°/s) while keeping his head sta-
tionary. Corrective (catch-up or back-up) saccades are lo-
oked for; they indicate a smooth pursuit gain that is too
low or too high. Many anatomical structures (visual cor-
tex, motion sensitive areas MT, V5, frontal eye fields, dor-
solateral pontine nuclei, cerebellum, vestibular and ocu-
lar motor nuclei) are involved in smooth pursuit eye mo-
vements, which keep the image of a moving object stable
on the fovea. These eye movements are also influenced by
alertness, various drugs, and age. Even healthy persons
exhibit a slightly saccadic smooth pursuit during vertical
downward gaze. For these reasons a saccadic smooth pur-
suit as a rule does not allow either an exact topographical
or etiological classification. Marked asymmetries of smooth
pursuit, however, indicate a structural lesion; strongly
impaired smooth pursuit is observed in intoxication
(anticonvulsives, benzodiazepines, or alcohol) as well as
degenerative disorders involving the cerebellum or extra-
pyramidal system. A reversal of slow smooth pursuit eye
movements during optokinetic stimulation is typical for
congenital nystagmus (see above).
To examine saccades it is first necessary to observe
spontaneous saccades triggered by visual or auditory sti-
muli. Then the patient is asked to glance back and forth
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between two horizontal and two vertical targets. The ve-
locity, accuracy, and the conjugacy of the saccades should
be noted. Normal individuals can immediately reach the
target with a fast single movement or one small corrective
saccade. Slowing of saccades –– often accompanied by
hypometric saccades – occurs for example with intoxica-
tion (medication, especially anticonvulsives or benzodia-
zepines) or in neurodegenerative disorders. Slowing of
horizontal saccades is generally observed in brainstem
lesions; there is often a dysfunction of the ipsilateral para-
median pontine reticular formation (PPRF). Slowing of
vertical saccades indicates a midbrain lesion in which the
rostral interstitial nucleus of the  medial longitudinal fa-
scicle (riMLF) is involved, not only in ischemic inflam-
matory diseases but also in neurodegenerative diseases,
especially progressive supranuclear palsy. Hypermetric
saccades, which can be identified by a corrective saccade
back to the object, indicate lesions of the cerebellum or
the cerebellar pathways. Patients with Wallenberg’s syn-
drome make hypermetric saccades toward the side of the
lesion due to a dysfunction of the inferior cerebellar pe-
duncle; defects of the superior cerebellar peduncle, con-
versely, lead to contralateral hypermetric saccades.
A slowing of the adducting saccade ipsilateral to a defective
MLF is pathognomonic for INO. Delayed onset saccades
are mostly caused by supratentorial cortical dysfunction.
Treatment of downbeat and upbeat nystagmus
with aminopyridines
Two types of vertically beating central nystagmus are
of special importance: downbeat nystagmus (DBN) and
upbeat nystagmus (UBN), each named after the direction
of the rapid, beating phase. Downbeat nystagmus is the
most common type of acquired, persistent nystagmus. Both
types manifest themselves above all with swaying nystag-
mus and unsteadiness of gait and only secondarily with
oscillopsia, i.e., apparent movement of the environment
due to oscillation of the retinal image. In distinction to
spontaneous nystagmus such as in vestibular neurits, DBN
and UBN are types of fixation nystagmus, i.e., their inten-
sity increases with visual fixation. Both DBN and UBN
always indicate the presence of a central disturbance and
possess special localizing significance. Downbeat nystag-
mus is usually due to bilateral dysfunction of the cerebel-
lar flocculus; its three common causes are cerebellar atro-
phy, ischemia, and Arnold-Chiari malformation. Upbeat
nystagmus –– which, unlike DBN, generally persists for
no more than a few weeks –– can be caused by parame-
dian medullary or pontomesenchephalic lesions, e.g., bra-
instem infarct or hemorrhage. A randomized, placebo-con-
trolled study of DBN has shown that the potassium-chan-
nel blockers 3,4-diaminopyridine and 4-aminopyridine can
significantly improve this type of nystagmus. The dosage
is 5–10 mg t.i.d.; follow-up ECG is necessary. The effecti-
veness of this treatment has since been confirmed by mul-
tiple studies. 4-aminopyridine seems to be effective aga-
inst UBN as well, but this has been documented to date
only in a single case study. The familial episodic ataxias
are rare genetic diseases of autosomal dominant transmis-
sion. There are at least two well-defined varieties. Type 2
(EA 2) is characterized by recurrent attacks of dizziness
and ataxia that are precipitated by physical activity, stress,
or alcohol and usually last for hours. In between attacks,
more than 90% of patients have marked central ocular
motor disturbances, often DBN. EA 2 is caused by muta-
tions in the CACNA1A gene (PQ calcium channel gene).
Most patients can be treated successfully with acetazola-
mide. If this treatment is ineffective, or if adverse effects
such as kidney stones develop, patients with EA 2 can
also be treated with 4-aminopyridine (5 mg t.i.d.). Amino-
pyridines are thus an effective treatment for DBN, UBN,
and EA 2 which is well tolerated at the low dose that is
generally used. These studies have also led to the deve-
lopment of a new principle of treatment; activation of ce-
rebellar Purkinje cells through potassium-channel bloc-
kade enhances the cerebellar inhibitory influence on the
vestibular and cerebellar nuclei.
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